Identification and functional analysis of regulators of senescence
Project/Area Number |
16H06148
|
Research Category |
Grant-in-Aid for Young Scientists (A)
|
Allocation Type | Single-year Grants |
Research Field |
Tumor biology
|
Research Institution | The University of Tokyo |
Principal Investigator |
|
Project Period (FY) |
2016-04-01 – 2019-03-31
|
Project Status |
Completed (Fiscal Year 2018)
|
Budget Amount *help |
¥27,430,000 (Direct Cost: ¥21,100,000、Indirect Cost: ¥6,330,000)
Fiscal Year 2018: ¥8,840,000 (Direct Cost: ¥6,800,000、Indirect Cost: ¥2,040,000)
Fiscal Year 2017: ¥8,840,000 (Direct Cost: ¥6,800,000、Indirect Cost: ¥2,040,000)
Fiscal Year 2016: ¥9,750,000 (Direct Cost: ¥7,500,000、Indirect Cost: ¥2,250,000)
|
Keywords | 老化 / 細胞周期 / 代謝 / がん / ゲノムワイド / 癌 / シグナル伝達 / p53 / ゲノムワイド解析 |
Outline of Final Research Achievements |
Senolytic removal of senescent cells (senolysis) has been proposed to be beneficial for improving various age-associated pathologies, but effective compounds as well as the molecular pathways for their senolytic activity have not yet emerged. In the present study, genome-wide shRNA screening identified GLS1 as an essential gene for survival of senescent cells. The intracellular pH in senescent cells was lowered by excess protein synthesis-mediated lysosomal membrane damage, and this lowered intracellular pH induced KGA-type GLS1 expression. Enhanced glutaminolysis then caused the production of ammonia which neutralized the lowered pH and improved survival of the senescent cells. GLS1 inhibitor treatment of aged mice eliminated senescent cells and ameliorated age-associated kidney dysfunction. Our results suggest that cells in a senescent state require glutaminolysis, and its inhibition offers a promising strategy for inducing senolysis in vivo.
|
Academic Significance and Societal Importance of the Research Achievements |
最近の研究により、加齢に伴う老化細胞の蓄積が老化・老年病発症の大きな要因の一つであることも分かりつつあり、老化細胞除去薬の開発が世界的に注目されている。本研究により、グルタミナーゼ阻害剤により老化細胞を選択的に除去することが可能となった。今後、より臨床に即した形でグルタミナーゼ阻害剤の研究を進めることで、動脈硬化症、腎障害、さらにはがんなどの加齢性疾病の治療・予防の新たな方法論の開発に大きく貢献できるものと考えられる。
|
Report
(4 results)
Research Products
(13 results)
-
[Journal Article] Cdk1-mediated DIAPH1 phosphorylation maintains metaphase cortical tension and inactivates the spindle assembly checkpoint at anaphase.2019
Author(s)
Nishimura K, Johmura Y, Deguchi K, Jiang Z, Uchida KSK, Suzuki N, Shimada M, Chiba Y, Hirota T, Yoshimura SH, Kono K, Nakanishi M.
-
Journal Title
Nature Communications
Volume: 10
Issue: 1
Pages: 1-10
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
[Journal Article] Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer.2018
Author(s)
Johmura Y, Maeda I, Suzuki N, Wu W, Goda A,Morita M, Yamaguchi K, Yamamoto M, Nagasawa S, Kojima Y, Tsugawa K, Inoue N, Miyoshi Y, Osako T Akiyama F, Maruyama R, Inoue JI, Fukukawa Y, Ohta T, Nkanishi M.
-
Journal Title
J Clin Invest.
Volume: 128
Issue: 12
Pages: 5603-5619
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy.2017
Author(s)
Iwata T, Uchino T, Koyama A, Johmura Y, Koyama K, Saito T, Ishiguro S, Arikawa T, Komatsu S, Miyachi M, Sano T, Nakanishi M, Shimada M.
-
Journal Title
Plos one
Volume: 12
Issue: 5
Pages: 1-13
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] A combination of genetic and biochemical analyses for the diagnosis of PI3K-AKT-mTOR pathway-associated megalencephaly.2017
Author(s)
Negishi Y, Miya F, Hattori A, Johmura Y, Nakagawa M, Ando N, Hori I, Togawa T, Aoyama K, Ohashi K, Fukumura S, Mizuno S, Umemura A, Kishimoto Y, Okamoto N, Kato M, Tsunoda T, Yamasaki M, Kanemura Y, Kosaki K, Nakanishi M, Saitoh S.
-
Journal Title
BMC Med Genet.
Volume: 18
Issue: 1
Pages: 4-4
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
-
[Book] 実験医学2017
Author(s)
城村由和、中西真
Total Pages
6
Publisher
羊土社
ISBN
9784758101677
Related Report